OPERF
RPRX icon

Oregon Public Employees Retirement Fund’s Royalty Pharma RPRX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,346
Closed -$937K – 1539
2023
Q4 		$937K Sell
33,346
-3,100
-9% -$85.2K 0.02% 919
2023
Q3 		$989K Sell
36,446
-14,586
-29% -$433K 0.01% 956
2023
Q2 		$1.57M Buy
+51,032
New +$1.73M 0.02% 758

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Oregon Public Employees Retirement Fund's RPRX Position: Q1 2024 in Review

Oregon Public Employees Retirement Fund sold out of Royalty Pharma (RPRX) in Q1 2024, closing a stake of 33,346 shares — an estimated $937K sold.

Oregon Public Employees Retirement Fund first reported a position in RPRX in Q2 2023 and held it in 3 quarters. The position peaked at $1.57M in Q2 2023. 378 funds tracked by Wall St. Rank hold RPRX as of Q1 2024.

  • Oregon Public Employees Retirement Fund reported no remaining Royalty Pharma position as of Q1 2024 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 33,346 Royalty Pharma shares in Q1 2024, an estimated $937K.
  • Oregon Public Employees Retirement Fund first reported a position in Royalty Pharma in Q2 2023 and held it in 3 quarters.
  • Oregon Public Employees Retirement Fund's Royalty Pharma position peaked at $1.57M in Q2 2023.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2024.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q1 2024, filed 3 May 2024.